Reassessing the role of antiphospholipid antibodies in placental‐mediated adverse pregnancy outcomes in systemic lupus erythematosus: A retrospective cohort study
International Journal of Gynecology & Obstetrics · 2026-12 · 175 (3) · 1314-1320
DOI: 10.1002/ijgo.71147 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 18.06.2026. Verfasst von Meng Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antibodies, Antiphospholipid, Pregnancy Outcome, Pregnancy Complications. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of College-Nominated NSFC General Program, National Key R&D Program of China.
Abstract (Originalsprache)
Objective
To examine how different antiphospholipid antibody (aPL) profiles influence placental‐mediated adverse pregnancy outcomes (APOs) in women with systemic lupus erythematosus (SLE).
Methods
This retrospective cohort study included 245 pregnant women with SLE and 490 controls from a single center. Clinical features, immunologic markers and aPL profiles were analyzed. Logistic regression models were used to explore associations between antiphospholipid syndrome (APS), individual aPL subtypes, antibody burden and placental‐mediated APOs.
Results
Placental‐mediated APOs occurred more often in SLE pregnancies than in controls (27.8% vs. 9.8%). After adjustment, APS was not independently associated with APOs. Renal involvement, chronic hypertension and hypocomplementemia remained significant predictors ( P < 0.05). Among antibody types, lupus anticoagulant (LAC) showed the strongest association in univariate analysis, but the effect weakened in multivariable analysis. Women with multiple aPL positivity had a higher risk of placental complications, whereas single positivity showed little independent effect.
Conclusion
In SLE pregnancies, obstetric risk is not explained by APS alone. Antibody burden, especially multiple aPL positivity, together with renal disease, hypertension and complement levels appears more informative for assessing placental‐related risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China.
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, International Centre for Reproductive Health (ICRH), Ghent University, Ghent, Belgium.
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Jiayue Wu
Förderung
- National Natural Science Foundation of China
- Project of College-Nominated NSFC General Program
- National Key R&D Program of China
- Project of College-Nominated NSFC Youth Program
Zitieren
APA
Jiang, M., Chang, Y., Zhang, N., Di, W., & Wu, J. (2026). Reassessing the role of antiphospholipid antibodies in placental‐mediated adverse pregnancy outcomes in systemic lupus erythematosus: A retrospective cohort study. International Journal of Gynecology & Obstetrics, 175(3), 1314-1320. https://doi.org/10.1002/ijgo.71147
Vancouver
Jiang M, Chang Y, Zhang N, Di W, Wu J. Reassessing the role of antiphospholipid antibodies in placental‐mediated adverse pregnancy outcomes in systemic lupus erythematosus: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 2026;175(3):1314-1320. doi:10.1002/ijgo.71147
BibTeX
@article{Jiang2026,
author = {Jiang, Meng and Chang, Yanling and Zhang, Ning and Di, Wen and Wu, Jiayue},
title = {Reassessing the role of antiphospholipid antibodies in placental‐mediated adverse pregnancy outcomes in systemic lupus erythematosus: A retrospective cohort study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
volume = {175},
number = {3},
pages = {1314--1320},
doi = {10.1002/ijgo.71147}
}
EUVIMED